- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02567357
Parents Resources for Decreasing the Incidence of Change Triggered Temper Outbursts (PREDICTORS)
PREDICTORS (Parents Resources for Decreasing the Incidence of Change Triggered Temper Outbursts)
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The aims of PREDICTORS are: 1. To refine the tools to implement and evaluate a resource-efficient caregiver training program for signalling changes to children with intellectual disabilities or autism spectrum disorders. 2. To pilot the program to test the feasibility of taking it forward into a clinical trial. 3. To conduct a process and economic evaluation of the pilot intervention to provide further data on its suitability for a clinical trial.
Parents/caregivers of children aged 7-16 years old who frequently show temper outbursts when things change in their routines or plans will keep a web-based diary accessed via smart phone or other device on their child's temper outbursts for a 6 month period (baseline). After 6 months of keeping this diary, parents/caregivers will then access web-based training for approximately 1 month which will include sessions to study once or twice per week as well as exercises to practice in between sessions.
After the training is complete parents will be asked to implement the strategies they have learnt in the 6 months that follow. In addition researchers from the university will telephone parents/ caregivers to ask some questions about their child's temper outbursts and on the effects this behaviour has on daily life. Parents will be interviewed at three points during the study (before baseline, after baseline, before intervention and after intervention phases). Interviews will focus on gathering information of their child's behaviour.
Focus groups with relevant experienced professionals and parents (not participating in the main part of the study) will guide the training resource development and development and content of the behaviour diary used by parents during the study.
Studietype
Registrering (Forventet)
Fase
- Fase 1
Kontakter og plasseringer
Studiesteder
-
-
Northern Ireland
-
Belfast, Northern Ireland, Storbritannia, BT7 1NN
- Queen's University Belfast
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- children aged 7-16 years of age, with temper outbursts triggered by change to routine or plans and their parent(s)/caregiver(s)
Exclusion Criteria:
- children who show less than one change triggered temper outburst (temper outbursts following an unexpected change in plan, routine or expectation) per month
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Visual Scheduling
A caregiver training package on the use of a pictorial (visual) schedule to illustrate each day's expected activities to a child.
Caregivers will be trained to ensure that activities occur as described in the schedule as far as possible, thus the expected mechanism of action is the reduction of (unexpected change) antecedents of children's temper outbursts.
|
Caregivers will present a visual schedule with pictorial representations of activities/events expected to occur each day will be presented to children at set times of day (tailored for individual's schedules).
Ultimately caregivers will aim to ensure that activities occur as per the schedule as far as possible - thus decreasing the child's level of exposure to unexpected changes in routines or plans.
Andre navn:
|
Eksperimentell: Signalling change
A caregiver training package where parents are taught to present a distinctive visual-verbal cue to a child whenever they become aware that a change will take place in the child's usual/expected activities.
Caregivers will be trained to only ever present to cue if they can be sure that a change to the child's routine or plan will occur, thus the expected mechanism of action is the child's learned association between the presentation of the cue and the subsequent occurrence of a change to their expectations.
Signalled changes will therefore be more predictable for the child, and should therefore be easier for them to deal with.
|
Caregivers will present a distinct visual-verbal cue card whenever they become aware that a change to the child's routine or plan is about to occur.
Thus, the intervention uses a stimulus control approach so that the child learns that presentation of the cue reliably predicts the subsequent occurrence of a change to routine/plan, and the change is therefore more predictable and easier for the child to deal with.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in frequency of temper outbursts between baseline and intervention
Tidsramme: 6 months baseline, 6 months during intervention
|
Informant reports of outbursts using a web-based behaviour diary after they occur. Entries comprise check lists of individual behaviours comprised in the outburst, an intensity rating (1-3 or 1-5 point scale depending on the different intensities of outburst parents were able to operationally describe), a description of the duration (<1 minute; >1 & <5 minutes; >5 & <15 minutes; >15 minutes & < 1 hour; >1 hour [specify]); a check list of possible antecedent events; and a check list of possible actions taken by caregivers. Frequency per month of temper outbursts following change-related antecedents of each intensity level and each duration will comprise the primary measurement. Reports will also be made every 3 days, of the number of outbursts over the previous 3 days (for validity checking); and of the number of changes to routines/plans experienced by the child. The percentage of changes that were followed by outbursts will comprise measurement 2. |
6 months baseline, 6 months during intervention
|
Change in percentage of changes to routines/plans experienced by children that are followed by temper outbursts between baseline and intervention
Tidsramme: 6 months baseline, 6 months during intervention
|
Informant reports will be made using a scheduled entry section of the behaviour diary, on the number of changes to routines /plans experienced by the child since the previous entry.
These data will be used to calculate the percentage of experienced changes that were followed by a temper outburst
|
6 months baseline, 6 months during intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in cost of services with which the child engages - Cost of Services Receipt Inventory
Tidsramme: within 2 weeks before baseline, within one month after baseline, within one month following intervention
|
An informant report questionnaire on the cost to health services associated with the child over the previous 6 months
|
within 2 weeks before baseline, within one month after baseline, within one month following intervention
|
Process information on how the intervention strategies are being implemented by caregivers
Tidsramme: every three days for 7 months from after baseline onwards
|
Informant report ratings on the use of the intervention strategy and how easy this was
|
every three days for 7 months from after baseline onwards
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Studieleder: Kate Woodcock, PhD, Queen's Univerisity Belfast
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- R2149PSY
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Barns atferd
-
MedDay Pharmaceuticals SAEurofins OptimedAvsluttetFriske Frivillige | Nedsatt leverfunksjon av moderat Child Pugh-kategoriFrankrike, Ungarn
-
RenJi HospitalFullførtBlodplateantall/miltdiameterforhold | Child-Pugh-klassifiseringKina
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)FullførtStoffbruk | Familieforhold | Risikofylt seksuell atferd | Runaway Behavior
-
Stanford UniversityNational Cancer Institute (NCI)AvsluttetTilbakevendende hepatocellulært karsinom | Child-Pugh klasse A | Child-Pugh klasse BForente stater, Japan
-
Jay ZuckermanFullførtUtviklingskoordinasjonsforstyrrelse | Utviklingsdyspraksi | Clumsy Child SyndromeIsrael
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsFullførtChild-Pugh klasse A | Stadium IIIA Hepatocellulært karsinom | Stadium IIIB Hepatocellulært karsinom | Stage IIIC hepatocellulært karsinom | Stage IVA Hepatocellulært karsinom | Stadium IVB hepatocellulært karsinom | Child-Pugh klasse BForente stater
-
Centre Hospitalier Universitaire DijonFullførtChild-Pugh A Hepatocellulært karsinomFrankrike
-
Centre Hospitalier Universitaire DijonFullførtIkke-opererbart ikke-metastatisk hepatocellulært karsinom | Child A/B7 CirrhoseFrankrike
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCAktiv, ikke rekrutterendeAvansert hepatocellulært karsinom hos voksne | Child-Pugh klasse A | Stadium III hepatocellulært karsinom | Stadium IIIA Hepatocellulært karsinom | Stadium IIIB Hepatocellulært karsinom | Stage IIIC hepatocellulært karsinom | Stadium IV hepatocellulært karsinom | Stage IVA Hepatocellulært karsinom | Stadium...Forente stater
-
AstraZenecaAvsluttetMagekreft | Avanserte solide maligniteter | Solid svulst | Child-Pugh A til B7 avansert hepatocellulært karsinom | EGFR og/eller ROS Mutant NSCLC | LungemetastasekarsinomKorea, Republikken
Kliniske studier på Visual Scheduling
-
University of California, Los AngelesCarnegie Mellon UniversityFullført
-
University of NebraskaRekruttering
-
University of Texas at AustinRekrutteringSlag | Sunn | Muskelsykdommer | Bevegelsesforstyrrelser | Motor Neuron sykdom | Traumatisk hjerneskade | Ryggmargsskader | Motoriske lidelserForente stater
-
University of LahoreFullførtAudiovisuelt triagesystem | Angstnivåer | Covid-19-spredning | GAD-7-poengsum | Helsepersonell | ScreeningstrategiPakistan
-
University of British ColumbiaBritish Columbia Children's Hospital; Providence Health & ServicesFullførtPostoperativ smerteCanada
-
Second Sight Medical ProductsNational Institute of Neurological Disorders and Stroke (NINDS)Aktiv, ikke rekrutterende
-
Universitair Ziekenhuis BrusselHar ikke rekruttert ennå
-
Sunnybrook Health Sciences CentreSuspendertArtroplastikk | Kne | ErstatningCanada
-
University of MiamiFullførtSynsfeltdefekt, perifert | Synsfeltdefekt, nesetrinn | Synsfeltdefekt, Paracentral Scotoma of Both EyesForente stater
-
Guy's and St Thomas' NHS Foundation TrustRekrutteringIntubasjon; Vanskelig eller mislykketStorbritannia